back insurance patient resources covid-19 response request records first visit info common clinical fees billing inquiries pay bill

Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045


Tobias Eckle, MD


Board Certified


Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045


Provider Expertise

Care Philosophy

I strive to provide the best patient care possible.


  • Anesthesiology ( 2008 , 2018 )

Education & Training

Medical Schools

MD, Eberhard Karls University, Tübingen - Germany (2001)

Professional Memberships

American Heart Association (AHA), Member

American Society of Anesthesiologists (ASA), Member

Association of University Anesthesiologists (AUA), Member

International Anesthesia Research Society (IARS), Member

Society of Cardiovascular Anesthesiologists (SCA), Member

Research & Grants


Myocardial Ischemic Preconditioning through Hypoxia Inducible Factor (HIF)-1 (2009)

Equilibrative Nucleoside Transporters (ENTs) in Cardiac Ischemic Preconditioning (2009)

Period in Cardioprotection (2010)

Intense Light Therapy for Perioperative Cardio-Protection (2015)

Targeting the endothelial clock to treat perioperative myocardial ischemia (2023)

Research Interests for Patients

My research interests are primarily focused on investigating the effect of daylight/sunlight on human metabolism.

information for referring providers

Referral Contact Phone

(720) 848-3264

Clinical Interests for Referring Providers

General Anesthesiology, Critical Care Medicine, Clinical Research

Research Interest for Referring Providers

Our research has been directed towards identifying cellular adaptive mechanisms during hypoxic conditions such as myocardial ischemia – one of the leading causes of morbidity and mortality worldwide. Epidemiologic studies in humans indicate that susceptibility to hypoxic events such as ischemic myocardial tissue injury is time-of-the-day dependent, with more severe injury occurring in the early morning hours after a longer period without daylight. Current findings from my lab indicate that light-exposure could function to attenuate ischemic myocardial injury. In fact, we observed a time-dependent reduction in myocardial infarct size and troponin I release following light treatment. A search for light inducible circadian rhythm proteins revealed a robust induction of cardiac Period 2(Per2) protein levels upon intense light exposure. Based on these findings, we hypothesize that intense light therapy provides robust cardio-protection by stabilizing cardiac Per2, thereby leading to concomitant cardio-protection from ischemia by optimizing metabolism on a cellular level. The long-term goal of our studies is to introduce intense light therapy into the hospital to prevent or treat hypoxic conditions such as myocardial injury in patients, the leading cause of morbidity and mortality worldwide.